Frank A. Damelio - Feb 23, 2022 Form 4 Insider Report for PFIZER INC (PFE)

Signature
Susan E. Grant, by power of atty., for Frank A. D'Amelio
Stock symbol
PFE
Transactions as of
Feb 23, 2022
Transactions value $
-$1,484,542
Form type
4
Date filed
2/25/2022, 05:04 PM
Previous filing
Feb 15, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $4.2M +154K +31.83% $27.34 637K Feb 23, 2022 Direct F1
transaction PFE Common Stock Tax liability -$1.79M -38.1K -5.98% $46.87 599K Feb 23, 2022 Direct F2
transaction PFE Common Stock Tax liability -$3.9M -76.1K -12.71% $51.28 523K Feb 23, 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -154K -100% $0.00* 0 Feb 23, 2022 Common Stock 154K $27.34 Direct
transaction PFE Stock Appreciation Rights Award $0 +127K $0.00 127K Feb 24, 2022 Common Stock 127K $45.96 Direct F5
transaction PFE Stock Appreciation Rights Award $0 +112K $0.00 112K Feb 24, 2022 Common Stock 112K $45.96 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F6 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.